LBB Specialties and Kerry Group Collaborate for Pharmaceutical Solutions
LBB Specialties and Kerry Group Partner for Pharmaceutical Lactose
LBB Specialties, a prominent distributor of specialty chemicals and ingredients, is thrilled to announce its collaboration with Kerry Group. This partnership aims to enhance the distribution of pharmaceutical lactose, elevating service levels in the life sciences sector.
Partnership Overview
Through this collaboration, LBB Specialties will serve as Kerry's preferred distribution partner, broadening access to high-quality pharmaceutical lactose ingredients. This partnership introduces Kerry's renowned Sheffield™ brand, offering a wide array of pharmaceutical lactose excipients crafted to meet the varying needs of formulators.
Kerry's Product Offering
Kerry's Sheffield™ brand encompasses an extensive collection of lactose excipients, available in different forms, grades, and particle sizes suitable for diverse pharmaceutical applications. This extensive range equips formulators with optimized solutions that address both innovative and traditional formulation challenges.
Commitment to Quality and Innovation
Seth Burns, Senior Vice President of Life Sciences at LBB Specialties, remarked, "Our partnership with Kerry enriches our customers' access to top-tier pharmaceutical lactose ingredients. Kerry's established technical prowess and dedication to product reliability introduce promising, high-performance solutions tailored to their specific requirements. Together, we are setting new standards for quality and innovation within pharmaceutical formulations."
Adequate Solutions for Formulators
Kerry offers an unparalleled range of lactose types, including anhydrous, spray-dried, and monohydrate grades, which play a critical role in the formulation process. Among these is the Sheffield™ brand N.F. Anhydrous Direct Tableting (DT) lactose, which has gained recognition as the industry standard for anhydrous direct compression lactose excipients, and Sheffield™ 316 Fast Flo® spray-dried lactose, both designed to enhance product consistency and optimize supply chain efficacy.
Joey Glassco, Regional Sales Manager for Pharma Excipients at Kerry, stated, "This agreement positions our customers to experience unrivaled access to Kerry's vast lactose portfolio, ensuring top-notch availability and exceptional customer service across the board."
Get in Touch for More Information
For those interested in exploring Kerry's innovative and sustainable specialty ingredients tailored for the Life Sciences realm, we encourage you to reach out to LBB Specialties. Their commitment to assisting you with your needs is unwavering.
About LBB Specialties
LBB Specialties stands at the forefront of specialty chemicals and ingredient distribution in North America. The company serves various markets including care, food & nutrition, industrial specialties, and life sciences.
About Kerry Group
Kerry Group is a leading partner specializing in taste and nutrition for the food, beverage, and pharmaceutical industries. The company is dedicated to innovating with its customers to create products that are not only palatable but also focus on nutrition and functionality while promoting sustainable practices. With a robust global research and development team, Kerry aims to address complex challenges facing its partners.
Frequently Asked Questions
What is the main purpose of the partnership between LBB Specialties and Kerry Group?
The partnership focuses on enhancing the distribution and availability of pharmaceutical lactose ingredients within the life sciences sector.
What products are included in Kerry's Sheffield™ brand?
Kerry's Sheffield™ brand includes a variety of pharmaceutical lactose excipients such as anhydrous direct tableting lactose and spray-dried lactose.
How does this partnership benefit formulators?
Formulators gain improved access to high-quality lactose ingredients, which helps them achieve product consistency and innovation in their applications.
Who is Seth Burns?
Seth Burns is the Senior Vice President of Life Sciences at LBB Specialties who emphasizes the importance of quality and innovation in pharmaceutical formulations.
What is Kerry Group's vision for the future?
Kerry Group aims to create sustainable nutrition solutions that will reach over two billion consumers by 2030, enhancing both health and environmental impact.
About The Author
Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.